Sacubitril-valsartan initiation in chronic heart failure patients impacts sleep apnea: the ENTRESTO-SAS study.
Continuous positive airway pressure
Heart failure
Sacubitril-valsartan
Sleep apnoea
Sleep-disordered breathing
Journal
ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
revised:
16
04
2021
received:
05
02
2021
accepted:
21
05
2021
pubmed:
9
6
2021
medline:
29
10
2021
entrez:
8
6
2021
Statut:
ppublish
Résumé
Optimizing medical cardiac treatment for sleep apnoea (SA) in patients with chronic heart failure and reduced ejection fraction (HFrEF) is an expert Grade C recommendation based on six studies encompassing a total of 67 patients only. Whether sacubitril-valsartan (SV), a cornerstone of HFrEF medical treatment, impacts SA is unknown and requires evaluation. The ENTRESTO-SAS trial is a six-centre, prospective, open-label real-life cohort study (NCT02916160). Ambulatory patients eligible for SV (i.e. HFrEF adults who remain symptomatic despite optimal treatment) were evaluated before and after 3 months of SV (including nocturnal ventilatory polygraphy); 118 patients were final analysed [median age was 66 (IQ In this real-life population, SV treatment for 3 months in SA patients is associated with a significant decrease in AHI. These results support the current guidelines that recommend first an optimization of the HFrEF treatment in patients with HFrEF and central SA. A potential positive airway pressure sparing effect merits further investigation.
Identifiants
pubmed: 34102018
doi: 10.1002/ehf2.13455
pmc: PMC8318447
doi:
Substances chimiques
Aminobutyrates
0
Biphenyl Compounds
0
Drug Combinations
0
Valsartan
80M03YXJ7I
sacubitril and valsartan sodium hydrate drug combination
WB8FT61183
Banques de données
ClinicalTrials.gov
['NCT02916160']
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2513-2526Informations de copyright
© 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
Références
Am Heart J. 2020 Dec;230:35-43
pubmed: 32980364
Eur J Heart Fail. 2017 Apr;19(4):579-587
pubmed: 28371141
Circulation. 2001 Feb 13;103(6):904-12
pubmed: 11171802
ESC Heart Fail. 2019 Dec;6(6):1161-1166
pubmed: 31701680
Nat Rev Cardiol. 2016 Jun;13(6):368-78
pubmed: 26935038
N Engl J Med. 2015 Sep 17;373(12):1095-105
pubmed: 26323938
Acta Cardiol Sin. 2016 Jul;32(4):387-96
pubmed: 27471351
ESC Heart Fail. 2020 Feb;7(1):158-166
pubmed: 31903729
JAMA. 2020 Apr 14;323(14):1389-1400
pubmed: 32286648
Circulation. 2010 Jul 27;122(4):352-60
pubmed: 20625114
Eur Respir J. 2017 Jan 18;49(1):
pubmed: 27920092
JACC Heart Fail. 2019 Nov;7(11):933-941
pubmed: 31521679
N Engl J Med. 2014 Sep 11;371(11):993-1004
pubmed: 25176015
Circulation. 2010 Apr 13;121(14):1598-605
pubmed: 20351237
BMC Med Ethics. 2020 Aug 13;21(1):72
pubmed: 32791969
Am J Respir Crit Care Med. 2011 Feb 15;183(4):539-46
pubmed: 20656940
Eur J Heart Fail. 2016 Apr;18(4):353-61
pubmed: 26869027
J Clin Sleep Med. 2016 May 15;12(5):757-61
pubmed: 27092695
JAMA Netw Open. 2020 Apr 1;3(4):e203088
pubmed: 32310283
ESC Heart Fail. 2018 Jun;5(3):222-230
pubmed: 29469206
J Clin Sleep Med. 2012 Oct 15;8(5):597-619
pubmed: 23066376
Heart Fail Rev. 2014 May;19(3):359-67
pubmed: 23681849
Am J Respir Crit Care Med. 2016 Mar 1;193(5):482-3
pubmed: 26930431
Eur Respir J. 2019 Sep 19;54(3):
pubmed: 31537655
Eur Respir J. 2019 Feb 7;53(2):
pubmed: 30759420
CJC Open. 2020 Apr 26;2(5):344-353
pubmed: 32995719
Eur J Heart Fail. 2012 Sep;14(9):1009-19
pubmed: 22730336
J Am Coll Cardiol. 2017 Feb 21;69(7):841-858
pubmed: 28209226
Am J Respir Crit Care Med. 2004 Mar 15;169(6):668-72
pubmed: 15003950
Eur J Heart Fail. 2016 Aug;18(8):891-975
pubmed: 27207191
Eur Heart J. 2015 Jun 14;36(23):1463-9
pubmed: 25636743
Int J Cardiol Heart Vasc. 2020 Feb 25;27:100486
pubmed: 32140553
Chest. 2007 Aug;132(2):440-6
pubmed: 17699130
Circ Cardiovasc Qual Outcomes. 2010 Nov;3(6):573-80
pubmed: 20923990
JAMA Intern Med. 2015 Jun;175(6):996-1004
pubmed: 25895156
ESC Heart Fail. 2021 Aug;8(4):2513-2526
pubmed: 34102018
Eur J Heart Fail. 2007 Mar;9(3):251-7
pubmed: 17027333
J Clin Med. 2020 Sep 29;9(10):
pubmed: 33003523
Open Heart. 2020 Oct;7(2):
pubmed: 33020255
Sleep. 1991 Dec;14(6):540-5
pubmed: 1798888
Sleep. 2012 Jan 01;35(1):17-40
pubmed: 22215916
Lancet Respir Med. 2016 Nov;4(11):873-881
pubmed: 27592224
Chest. 2008 Mar;133(3):690-6
pubmed: 18198253
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
J Card Fail. 2007 Feb;13(1):50-5
pubmed: 17339003
Can Respir J. 2010 Jul-Aug;17(4):170-4
pubmed: 20808975
Circulation. 2007 Jun 26;115(25):3173-80
pubmed: 17562959